
Credit Claiming Only - NAPBC: De-escalation of Breast Cancer Therapy: Bringing Medical, Radiation Surgical Oncology together in Patient Centered Care
Overview
Recent clinical trials results support the de-escalation of treatment for specific groups of patients with breast cancer where care outcomes are non-inferior with less rather than more extensive treatment. Conservative treatment can be both safe and effective and results in fewer complications and sequelae that affect the patient’s quality of life. The speakers participating in this interactive webinar will discuss surgical, radiation, and systemic treatment options for three sample cases sharing the evidence for de-escalation for each case.
Target Audience
• Breast Program Directors
• Medical Oncologists
• Radiation Oncologists
• Cancer Liaison Physicians and State Chairs
• Breast Program Administrators
• Cancer Program Administrators
• Advance Practice Nurses
• Physician Assistants
• Navigators
• Genetic Counselors
• Oncology Data Specialist
• Program Coordinators
Learning Objectives
1. Describe indications when in women over 70 where de-escalation of surgery, radiation and endocrine therapy are needed for early-stage breast cancer
2. Describe indications for de-escalation of surgery, radiation and drug therapy after neoadjuvant therapy for node positive breast cancer
3. Describe indications for choice of endocrine and/or chemotherapy for post-menopausal ER+ women, and the role of tumor profiling, axillary surgery and radiotherapy in these patients.
Contact
- For questions regarding the course content, please contact NAPBC @facs.org.
- For general questions regarding Cancer Program, please contact CancerProgramsEvents@facs.org
- For any technical questions, please contact us at learning@facs.org.
Faculty
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
- Ineligible Company: The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
- Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
- Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Accreditation
Continuing Medical Education Credit Information
Accreditation
The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
The American College of Surgeons designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Credit Claiming Information
All learners must complete the course evaluation in order to claim a CME Certificate. Participants may only claim a maximum of 1 AMA PRA Category 1 Credits™.
Award of CME credits by ACS is based on compliance of the program with the ACCME accreditation requirements and does not imply endorsement by ACS of the content, the faculty, or the sponsor of the program.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program.
Diplomates of the American Board of Surgery
By attending an ACS-accredited activity, you may choose to participate in the automatic transfer of your CME credits to the ABS via the ACCME. The direct automatic transfer applies to all learners who have an American College of Surgeons (ACS) profile, are Diplomates of the ABS, and have provided their ABS ID and date of birth in the ACS MyCME Portal on the Board Certification page.
If you do not already have an American College of Surgeons (ACS) profile (Learner ID), you can create one through the ACS New User Registration Form. This is a free offering for those who have enrolled in an ACS- Accredited educational activity. The ACS ID will grant you access to MyCME where you can track, manage, and send your CME Data to the ABS.
If you need assistance with creating an ACS Learner ID or are not certain if you already have one, please contact Log-In Help.
For more information or to request assistance, contact mycme@facs.org
A Certificate of Completion will be awarded for this course.
Credit is approved by the National Cancer Registrars Association (NCRA) #2025-128. for 1 contact hour.
ACS Cancer Programs is an approved provider by the California Board of Registered Nursing, provider #CEP17437, for 1 contact hour.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 CE Contact hours
- 1.00 Certificate of Completion